Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)

被引:2
|
作者
Devpura, S. [1 ]
Siddiqui, M. S. [1 ]
Chen, D. [1 ]
Liu, D. [1 ]
Li, H. [1 ]
Kumar, S. [1 ]
Gordon, J. [1 ]
Ajlouni, M. [1 ]
Movsas, B. [1 ]
Chetty, I. J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源
XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013) | 2014年 / 489卷
关键词
MONTE-CARLO; RADIATION-THERAPY; PHOTON BEAMS; ALGORITHM; VMC;
D O I
10.1088/1742-6596/489/1/012007
中图分类号
O59 [应用物理学];
学科分类号
摘要
The purpose of this study was to systematically evaluate dose distributions computed with 5 different dose algorithms for patients with lung cancers treated using stereotactic ablative body radiotherapy (SABR). Treatment plans for 133 lung cancer patients, initially computed with a 1D-pencil beam (equivalent-path-length, EPL-1D) algorithm, were recalculated with 4 other algorithms commissioned for treatment planning, including 3-D pencil-beam (EPL-3D), anisotropic analytical algorithm (AAA), collapsed cone convolution superposition (CCC), and Monte Carlo (MC). The plan prescription dose was 48 Gy in 4 fractions normalized to the 95% isodose line. Tumors were classified according to location: peripheral tumors surrounded by lung (lung-island, N=39), peripheral tumors attached to the rib-cage or chest wall (lung-wall, N=44), and centrally-located tumors (lung-central, N=50). Relative to the EPL-1D algorithm, PTV D95 and mean dose values computed with the other 4 algorithms were lowest for "lung-island" tumors with smallest field sizes (3-5 cm). On the other hand, the smallest differences were noted for lung-central tumors treated with largest field widths (7-10 cm). Amongst all locations, dose distribution differences were most strongly correlated with tumor size for lung-island tumors. For most cases, convolution/superposition and MC algorithms were in good agreement. Mean lung dose (MLD) values computed with the EPL-1D algorithm were highly correlated with that of the other algorithms (correlation coefficient =0.99). The MLD values were found to be similar to 10% lower for small lung-island tumors with the model-based (conv/superposition and MC) vs. the correction-based (pencil-beam) algorithms with the model-based algorithms predicting greater low dose spread within the lungs. This study suggests that pencil beam algorithms should be avoided for lung SABR planning. For the most challenging cases, small tumors surrounded entirely by lung tissue (lung-island type), a Monte-Carlo-based algorithm may be warranted.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Stereotactic body radiotherapy in lung cancer: an update
    Cintra Vita Abreu, Carlos Eduardo
    Rodrigues Ferreira, Paula Pratti
    de Moraes, Fabio Ynoe
    Pimenta Neves, Wellington Furtado, Jr.
    Gadia, Rafael
    Carvalho, Heloisa de Andrade
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2015, 41 (04) : 376 - 387
  • [32] A strategy to reduce fraction number in peripheral lung stereotactic ablative body radiotherapy
    O'Keeffe, Serena
    Higgins, Martin J.
    Fleming, Cathy
    Armstrong, John
    Thirion, Pierre
    McClean, Brendan
    Vintro, Luis Leon
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 26
  • [33] Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
    Peng, Jiayuan
    Zhang, Zhen
    Wang, Jiazhou
    Xie, Jiang
    Hu, Weigang
    ONCOTARGET, 2016, 7 (16) : 22523 - 22530
  • [34] Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy
    Onal, Cem
    Guler, Ozan Cem
    Yildirim, Berna Akkus
    BREAST, 2018, 42 : 150 - 156
  • [35] Patient, tumour, and dosimetric factors influencing survival in non-small cell lung cancer patients treated with stereotactic ablative body radiotherapy
    Padden-Modi, Minal
    Spivak, Yevhen
    Gleeson, Ian
    Robinson, Andrew
    Jayaprakash, Kamalram Thippu
    BJR OPEN, 2024, 6 (01):
  • [36] Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose
    Zhu, Simeng
    Lightsey, Judith L.
    Hoppe, Bradford S.
    Okunieff, Paul
    Gopalan, Priya K.
    Kaye, Frederic J.
    Morris, Christopher G.
    Yeung, Anamaria R.
    CANCER INVESTIGATION, 2018, 36 (05) : 289 - 295
  • [37] Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer
    Kron, Tomas
    Chesson, Brent
    Hardcastle, Nicholas
    Crain, Melissa
    Clements, Natalie
    Burns, Mark
    Ball, David
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1085)
  • [38] Evaluation of functionally weighted dose-volume parameters for thoracic stereotactic ablative radiotherapy (SABR) using CT ventilation
    Kanai, Takayuki
    Kadoya, Noriyuki
    Nakajima, Yujiro
    Miyasaka, Yuya
    Ieko, Yoshiro
    Kajikawa, Tomohiro
    Ito, Kengo
    Yamamoto, Takaya
    Dobashi, Suguru
    Takeda, Ken
    Nemoto, Kenji
    Jingu, Keiichi
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 49 : 47 - 51
  • [39] Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer
    Tsuruta, Yusuke
    Nakata, Manabu
    Nakamura, Mitsuhiro
    Matsuo, Yukinori
    Higashimura, Kyoji
    Monzen, Hajime
    Mizowaki, Takashi
    Hiraoka, Masahiro
    MEDICAL PHYSICS, 2014, 41 (08) : 189 - 197
  • [40] Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer
    Trakul, Nicholas
    Koong, Albert C.
    Chang, Daniel T.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 140 - 147